Alpha-internexin as a brain-specific neurodegeneration marker: development and validation of a novel CSF assay

We developed a highly sensitive and specific immunoassay for AINX in CSF. AINX showed similar diagnostic performance and high correlation with CSF NfL. Further research should focus on describing its role in specific disorders, as well as evaluate its potential as a blood-based biomarker.

Authors

Institutions

Publication Details

Journal
Journal of Neurology
Published
2025-10-01
DOI
https://doi.org/10.1007/s00415-025-13428-y
Citations
2
Primary Topic
RNA Research and Splicing
Type
article
Field-Weighted Citation Impact
1.61

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Alpha-internexin as a brain-specific neurodegeneration marker: development and validation of a novel CSF assay

Gunnar Brinkmalm, Edward J. Wild, Claire A. Leckey, Hlin Kvartsberg et al.
2 citations
Journal of Neurology
RNA Research and Splicing
1.61
article

Alpha-internexin as a brain-specific neurodegeneration marker: development and validation of a novel CSF assay

Gunnar Brinkmalm, Edward J. Wild, Claire A. Leckey, Hlin Kvartsberg, Ulf Andréasson, Francisco J. Meda, Anna Dittrich, Ross W. Paterson, Silke Kern, Ingmar Skoog, Henrik Zetterberg, Kaj Blennow
article en
2 citations

Abstract

We developed a highly sensitive and specific immunoassay for AINX in CSF. AINX showed similar diagnostic performance and high correlation with CSF NfL. Further research should focus on describing its role in specific disorders, as well as evaluate its potential as a blood-based biomarker.

Journal of NeurologyVol. 272(10)
University of Wisconsin–Madison (US), Sahlgrenska University Hospital (SE), Huntington's Disease Association (GB), Institute for Neurodegenerative Disorders (US), UK Dementia Research Institute (GB), National Hospital for Neurology and Neurosurgery (GB), University College London (GB), Indian Institute of Science Bangalore (IN), University of Gothenburg (SE)
Alzheimer's Association, Alzheimer's Drug Discovery Foundation, CHDI Foundation, Familjen Erling-Perssons Stiftelse, Cure Alzheimer's Fund, Stiftelsen för Gamla Tjänarinnor, EU Joint Programme – Neurodegenerative Disease Research, European Huntington's Disease Network, National Institute for Health and Care Research, University College London, European Commission, Hjärnfonden, Vetenskapsrådet, Stiftelsen Psykiatriska Forskningsfonden, Alzheimerfonden, UK Dementia Research Institute, Fondation pour la Recherche sur Alzheimer, HORIZON EUROPE Framework Programme
Openalex Percentile: Top 14%
RNA Research and Splicing
1.61
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.